Indaptus Registers 58.9M Shares for Resale — 44% of Outstanding

summarizeSummary

Indaptus filed an S-3 to register 58.9 million shares for resale by selling stockholders, equal to 44% of shares outstanding. The company receives no proceeds; the registration creates a massive potential overhang on the stock.

check_boxKey Events · Financing and Capital Events · INDP

• 58.9M Shares Registered for Resale

  The S-3 registers 58,895,000 shares for resale by selling stockholders, representing approximately 44.2% of the 133,242,324 shares outstanding as of the prospectus date.

• No Proceeds to Company

  All net proceeds from the sale of the registered shares will go to the selling stockholders; the company will not receive any proceeds.

• Sino Lion Ventures Largest Seller

  Sino Lion Ventures Limited is registering 38,895,000 shares (29.19% of outstanding), acquired through conversion of 259,300 Series AAA Preferred Stock originally issued to David Lazar in December 2025.

• June 2026 Placement Shares Included

  The registration also covers 20,000,000 shares issued in the June 17, 2026 private placement at $0.60 per share, for which the company received $12 million in gross proceeds.

auto_awesomeAnalysis · INDP · Life Sciences

This S-3 registers 58,895,000 shares for resale by selling stockholders, representing approximately 44.2% of the company's 133,242,324 outstanding shares. The registration includes 20 million shares from the June 2026 private placement and 38.9 million shares from the conversion of Series AAA Preferred Stock held by Sino Lion Ventures Limited. The company will receive no proceeds from these sales. The sheer size of the registered overhang — nearly half the company — creates significant potential selling pressure on the stock, especially given the company's going concern warning and lack of active clinical programs. The prior S-3 filed June 26, 2026 registered only 18.86 million shares, so this filing materially expands the resale capacity.